SLAMF1 as a Risk Biomarker for Nontraumatic SAH: Evidence From a Multiomics Study. - Renedo D; Koo AB; Sujijantarat N; Clocchiatti-Tuozzo S; Huo S; Acosta JN; Hebert R; Gunel M; Sansing LH; Sheth KN; Falcone GJ; Matouk CC; et al. (Stroke, 2026)